Your browser doesn't support javascript.
loading
Dual Inhibition of EGFR and c-Src by Cetuximab and Dasatinib Combined with FOLFOX Chemotherapy in Patients with Metastatic Colorectal Cancer.
Parseghian, Christine M; Parikh, Nila U; Wu, Ji Yuan; Jiang, Zhi-Qin; Henderson, Laura; Tian, Feng; Pastor, Brice; Ychou, Marc; Raghav, Kanwal; Dasari, Arvind; Fogelman, David R; Katsiampoura, Anastasia D; Menter, David G; Wolff, Robert A; Eng, Cathy; Overman, Michael J; Thierry, Alain R; Gallick, Gary E; Kopetz, Scott.
Afiliação
  • Parseghian CM; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas. cparseghian@mdanderson.org.
  • Parikh NU; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wu JY; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Jiang ZQ; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Henderson L; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Tian F; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Pastor B; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
  • Ychou M; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
  • Raghav K; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Dasari A; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Fogelman DR; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Katsiampoura AD; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Menter DG; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Wolff RA; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Eng C; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Overman MJ; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Thierry AR; IRCM, Institut de Recherche en Cancérologie de Montpellier, Montpellier, France.
  • Gallick GE; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Kopetz S; Department of Gastrointestinal Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Clin Cancer Res ; 23(15): 4146-4154, 2017 Aug 01.
Article em En | MEDLINE | ID: mdl-28280091
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) / Quinases da Família src / Receptores ErbB / Dasatinibe / Cetuximab Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Proteínas Proto-Oncogênicas p21(ras) / Quinases da Família src / Receptores ErbB / Dasatinibe / Cetuximab Idioma: En Ano de publicação: 2017 Tipo de documento: Article